SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biochem Pharma (BCHE) -- Ignore unavailable to you. Want to Upgrade?


To: Jim Oravetz who wrote (669)10/21/1999 11:20:00 PM
From: tuck  Respond to of 783
 
Jim,

It can stay in a trading range for a while and make me very happy. I'm using it as a vehicle for covered call writing. If it can stay in business for a while and be a bit volatile, that's just fine. I bought in here because I don't see much downside for a while unless it gets caught in a general shelling. Investors will have to give management time to show whether or not they can transform the company into an independent big pharma.

Cheers, Tuck



To: Jim Oravetz who wrote (669)10/22/1999 11:58:00 AM
From: Jim Oravetz  Read Replies (1) | Respond to of 783
 
BioChem Pharma COO details two successful product launches, two more in testing
Jacques R. Lapointe, BioChem Pharma Inc.

archive.twst.com

Jim